BabyCue is an Odisha-based startup in the health tech segment. BabyCue Private Ltd. has secured considerable national recognition by winning an award of ₹5 lakh at the Tribal Business Conclave 2026. The company has received this distinction by virtue of winning the national innovation challenge for its revolutionary point-of-care diagnostic test especially made for children. This enterprise from Cuttack, Odisha, which has been recognized by DPIIT, has developed the DiaCue diagnostic test kit to overcome various problems faced in the pediatric healthcare segment in rural and tribal areas.

Impact and core innovation

Traditional knowledge of the national success of BabyCue lies in its groundbreaking brainchild, DiaCue, a point-of-care diagnostic test kit that can identify and categorise both bacterial and non-bacterial diarrhoea in children in 15-20 minutes. Childhood diarrheal diseases continue to present a serious health risk in tribal and rural areas, with delayed diagnosis and a lack of access to sophisticated pathological laboratories often resulting in inappropriate treatment. 

Presently, the standard diagnostic approach demands specialized laboratory facilities and long waiting periods, hindering timely medical response or indiscriminate antibiotic dispensing. Combining biotechnology and material science, DiaCue empowers healthcare providers at the front lines and clinicians with rapid, accurate diagnostic clarity at the point of care.

The Open Grand Challenge awarded at the Tribal Business Conclave highlights the contextual relevance and scalability of DiaCue’s solution for the tribal population of India. The prompt provision of diagnostic screening in remote tribal regions has the potential to have a significant impact on child morbidity and mortality rates. 

In addition to helping clinical intervention, DiaCue’s rapid differentiation supports responsible antibiotic stewardship. Healthcare systems and workers can identify non-bacterial diarrhoea cases within 15–20 minutes, avoiding the use of unnecessary antibiotics and thus reducing the global rise of antimicrobial resistance, while delivering focused, efficient treatment to patients.

Recognition and institutional support for indigenous healthtech

The Tribal Business Conclave is a national platform to catalyse innovations in context, innovations that are scalable and solutions to the developmental challenges being faced by tribal communities in India. 

The Open Grand Challenge was designed to inspire entrepreneurs and foster linkages between grassroots innovations and institutional support, and was used to review many solutions related to healthcare, livelihoods, and community welfare. 

The victory demonstrates the flexibility of BabyCue’s diagnostic tool to deliver actionable insights for healthcare planning, with the ₹5 lakh awarded in alignment with healthcare trends in India. The recognition supports the rapid expansion of DiaCue in remote health centers and tribal districts through financial and institutional support.

Since inception, BabyCue has established a strong presence in the Indian biotechnology and startup landscape, with a mission to safeguard child health through early detection. 

The startup had already won institutional support for its indigenous rapid diagnostic platform before it went successful at the Tribal Business Conclave, thus providing proof of scientific rigour and commercial viability to its technology. 

BabyCue is a diagnostic kit that integrates digital tools that aid early screening, and is an example of how locally developed research can result in manufacturing cost-effective medical devices that address Indian healthcare needs.

Conclusion

The ₹5 lakh win at the Tribal Business Conclave 2026 is a significant achievement for Odisha-based startups, particularly BabyCue, in the realm of pediatric healthtech innovation. The company’s fast diagnostic test, DiaCue, provides a practical, scalable solution for managing childhood diarrhea in underserved and tribal areas by producing results in 15 to 20 minutes. BabyCue’s innovation is poised to make a significant impact on child health in India by bringing national exposure to the brand, providing a platform for the company to deepen its footprint in point-of-care diagnostics, and showcasing the impact that its indigenous medical technology can have on child health outcomes in India.